Sarcopenia and osteoporosis in tobacco- and non-tobacco-exposure-related chronic obstructive pulmonary disease

Read full text Summarise with VIRAT
Authors: Uma Maheswari Krishnaswamy, Kavitha Venkatnarayan, Rebecca Kuriyan Raj, Sumithra Selvam, Chitra Veluthat, Priya Ramachandran, Uma Devaraj
Cited by: 0
References: 21

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Sarcopenia and osteoporosis are important comorbidities in patients with chronic obstructive pulmonary disease (COPD). We compared the prevalence and impact of these comorbidities in tobacco-smoke-related COPD (S-COPD) and non-tobacco-smoke-related COPD (NS-COPD). The utility of rectus femoris ultrasonography as a screening tool for sarcopenia was also explored. This cross-sectional study was conducted in a tertiary care hospital in Southern India. The COPD Assessment Test (CAT), St. George's Respiratory Questionnaire, 6-minute walk test, dual energy X-ray absorptiometry and rectus femoris ultrasonography were performed in all included participants. One hundred participants (73% S-COPD and 27% NS-COPD, respectively) were included with a mean (standard deviation - SD) age of 65.8 (8.6) years and a mean (SD) predicted forced expiratory volume at one second of 41.1% (12.6). NS-COPD participants were younger (60.7 vs. 67.5 years; p

Fields of Study & Subjects

Chronic Obstructive Pulmonary Disease (COPD) Research Nutrition and Health in Aging Muscle Physiology and Disorders

Publication details

Journal / source
Monaldi Archives for Chest Disease
Publication date
31 March 2026
Language
EN